2023
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes
HÁJKOVÁ, Nikola, Michaela BÁRTŮ KENDALL, David CIBULA, Jana DROZENOVÁ, Pavel FABIAN et. al.Základní údaje
Originální název
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes
Autoři
HÁJKOVÁ, Nikola (203 Česká republika), Michaela BÁRTŮ KENDALL (203 Česká republika), David CIBULA (203 Česká republika), Jana DROZENOVÁ (203 Česká republika), Pavel FABIAN (203 Česká republika), Oluwole FADARE, Filip FRÜHAUF (203 Česká republika), Jitka HAUSNEROVÁ (203 Česká republika, domácí), Jan HOJNÝ (203 Česká republika), Eva KRKAVCOVÁ (203 Česká republika), Jan LACO (203 Česká republika), Sigurd F LAX, Radoslav MATĚJ (203 Česká republika), Gábor MÉHES, Romana MICHÁLKOVÁ (203 Česká republika), Kristýna NĚMEJCOVÁ (203 Česká republika), Naveena SINGH, Simona STOLNICU (203 Česká republika), Marián ŠVAJDLER (203 Česká republika), Tomáš ZIMA (203 Česká republika), Wilson Glenn MCCLUGGAGE, Ivana STRUŽINSKÁ (203 Česká republika) a Pavel DUNDR (203 Česká republika)
Vydání
Translational research, NEW YORK, ELSEVIER SCIENCE INC, 2023, 1931-5244
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30109 Pathology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 7.800 v roce 2022
Kód RIV
RIV/00216224:14110/23:00131347
Organizační jednotka
Lékařská fakulta
UT WoS
001067763800001
Klíčová slova anglicky
non-endometrioid ovarian epithelial tumors; microsatellite instability
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 12. 1. 2024 13:39, Mgr. Tereza Miškechová
Anotace
V originále
Testing of microsatellite instability is not only used as a triage for possible Lynch syndrome, but also to predict immunotherapy treatment response. The aim of this study was to assess the frequency of mismatch repair deficiency (MMR-D)/microsatellite instability (MSI) in 400 cases of non-endometrioid ovarian tumors (high-grade serous, low-grade serous, mucinous and clear cell), to compare different methodological approaches of testing, and to assess the optimal approach for next generation sequencing (NGS) MSI testing. For all tumors, we evaluated immunohistochemical (IHC) expression of MMR proteins and assessed microsatellite markers by PCR-based method. Except for high-grade serous carcinoma, we correlated the findings of IHC and PCR with NGS-based MSI testing. We compared the results with somatic and germline mutation in MMR genes. Among the whole cohort, seven MMR-D cases, all clear cell carcinomas (CCC), were found. On PCR analysis, 6 cases were MSI-high and one was MSS. In all cases, mutation of an MMR gene was found; in 2 cases, the mutation was germline (Lynch syndrome). An additional 5 cases with a mutation in MMR gene(s) with MSS status and without MMR-D were identified. We further utilized sequence capture NGS for MSI testing. Employing 53 microsatellite loci provided high sensitivity and specificity. Our study shows that MSI occurs in 7% of CCC while it is rare or absent in other nonendometrioid ovarian neoplasms. Lynch syndrome was present in 2% of patients with CCC. However, some cases with MSH6 mutation can evade all testing methods, including IHC, PCR, and NGS-MSI.
Návaznosti
90233, velká výzkumná infrastruktura |
|